Shekhar Saha and colleagues reported that DRAIC exerts its tumor suppressive function by modulating Glucose transporter 1 (GLUT1) expression to deliver signals from IKK/NF-κB to the AMPK/mTOR pathway. The gene discussed is MTOR; the disease is neoplasm.